Patents by Inventor Marko Djerek

Marko Djerek has filed for patents to protect the following inventions. This listing includes patent applications that are pending as well as patents that have already been granted by the United States Patent and Trademark Office (USPTO).

  • Patent number: 7202221
    Abstract: The present invention relates to 14 or 15 membered macrolides substituted at the 4? position of formula (I) and pharmaceutically acceptable salts and solvates thereof, to processes for their preparation and their use in therapy or prophylaxis of systemic or topical bacterial infections in a human or animal body
    Type: Grant
    Filed: November 13, 2002
    Date of Patent: April 10, 2007
    Assignees: Glaxo Group Limited, Pliva D.D.
    Inventors: Suleman Alihodzic, Daniele Andreotti, Andrea Berdik, Ilaria Bientinesi, Stefano Biondi, Manuela Ciraco, Federica Damiani, Marko Djerek, Miljenko Dumic, Vesna Erakovic, Antun Hutinec, Gorjana Lazarevski, Sergio Lociuro, Natasa Marsic, Zorica Marusic-Istuk, Stjepan Mutak, Alfredo Paio, Drazen Pavlovic, Anna Quaglia, Wolfgang Schoenfeld, Vlado Stimac, Jessica Tibasco
  • Publication number: 20050080025
    Abstract: The present invention relates to 14 or 15 membered macrolides substituted at the 4th position of formula (I) and pharmaceutically acceptable salts and solvates thereof, to processes for their preparation and their use in therapy or prophylaxis of systemic or topical bacterial infections in a human or animal body.
    Type: Application
    Filed: November 13, 2002
    Publication date: April 14, 2005
    Inventors: Suleman Alihodzic, Daniele Andretoh, Andrea Berdik, Ilaria Bientinesi, Stefano Biondi, Manuela Ciraco, Federica Damiani, Marko Djerek, Miljenko Dumic, Vesna Erakovic, Antun Hutinec, Gorjana Lazarevski, Sergio Lociuro, Natasa Marsic, Zorica Marusic-Istuk, Stjepan Mutak, Alfred Paio, Drazen Pavlovic, Anna Quaglia, Wolfgang Schoenfeld, Vlado Stimac, Jessica Tibasco
  • Patent number: 6504035
    Abstract: The present invention relates to derivatives of 3-deoxy desmycosin of the formula I, wherein, starting from triply protected desmycosin, there are performed an oxidation at C-3 in the first step and then, optionally, a hydrogenation of double bonds and an epoxidation followed by a reductive opening of the oxirane ring. The present invention also relates to derivatives of 3-deoxy-desmycosin of the formula II, wherein in the first step triacetyl desmycosin is hydrogenated and then, via an intermediate mesylate, it is converted to a 2,3-didehydro derivative; or 2,3-didehydro-desmycosin is subjected to epoxidation reactions followed by a reductive opening of the oxirane ring.
    Type: Grant
    Filed: January 28, 2002
    Date of Patent: January 7, 2003
    Assignee: PLIVA, farmaceutska industrija, dionicko drustvo
    Inventors: Amalija Narandja, Nevenka Lopotar, Marko Djerek, Dra{haeck over (z)}en Pavlović